메뉴 건너뛰기




Volumn 27, Issue 9, 2013, Pages 808-816

Attractiveness of reformulated OxyContin® tablets: Assessing comparative preferences and tampering potential

Author keywords

Addiction; analgesics; drug administration routes; drug reformulation; opiate addiction; opiate dependence; opioid analgesics; oxycodone; OxyContin; prescription drug abuse; tamper resistant drugs

Indexed keywords

NARCOTIC ANALGESIC AGENT; OXYCODONE;

EID: 84883323504     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881113493364     Document Type: Article
Times cited : (34)

References (39)
  • 1
    • 79953748230 scopus 로고    scopus 로고
    • Association between opioid prescribing patterns and opioid overdose-related deaths
    • Bohnert ASB, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. J Am Med Ass. 2011 ; 305: 1315-1321
    • (2011) J Am Med Ass , vol.305 , pp. 1315-1321
    • Asb, B.1    Valenstein, M.2    Bair, M.J.3
  • 3
    • 67650069173 scopus 로고    scopus 로고
    • Can abuse deterrent formulations make a difference? Expectation and speculation
    • Budman SH, Grimes Serrano JM, Butler SF. Can abuse deterrent formulations make a difference? Expectation and speculation. Harm Reduct J. 2009 ; 6: 8
    • (2009) Harm Reduct J , vol.6 , pp. 8
    • Budman, S.H.1    Grimes Serrano, J.M.2    Butler, S.F.3
  • 4
    • 80054118887 scopus 로고    scopus 로고
    • Abuse risks and routes of administration of different prescription opioid compounds and formulations
    • Butler SF, Black RA, Cassidy TA, et al. Abuse risks and routes of administration of different prescription opioid compounds and formulations. Harm Reduct J. 2011 ; 8: 29
    • (2011) Harm Reduct J , vol.8 , pp. 29
    • Butler, S.F.1    Black, R.A.2    Cassidy, T.A.3
  • 5
    • 84883364148 scopus 로고    scopus 로고
    • Abuse rates and routes of administration of reformulated extended-release oxycodone: Initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment
    • Butler SF, Cassidy TA, Chilcoat H, et al. Abuse rates and routes of administration of reformulated extended-release oxycodone: Initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment. J Pain. 2013 ; 14 (4). 351-358
    • (2013) J Pain , vol.14 , Issue.4 , pp. 351-358
    • Butler, S.F.1    Cassidy, T.A.2    Chilcoat, H.3
  • 6
    • 74049140024 scopus 로고    scopus 로고
    • Measuring attractiveness for abuse of prescription opioids
    • Butler SF, Fernandez KC, Chang A, et al. Measuring attractiveness for abuse of prescription opioids. Pain Med. 2010 ; 11: 67-80
    • (2010) Pain Med , vol.11 , pp. 67-80
    • Butler, S.F.1    Fernandez, K.C.2    Chang, A.3
  • 7
    • 36749032377 scopus 로고    scopus 로고
    • Prescription OxyContin abuse among patients entering addiction treatment
    • Carise D, Dugosh KL, McLellan AT, et al. Prescription OxyContin abuse among patients entering addiction treatment. Am J Psychiatry. 2007 ; 164: 1750-1756
    • (2007) Am J Psychiatry , vol.164 , pp. 1750-1756
    • Carise, D.1    Dugosh, K.L.2    McLellan, A.T.3
  • 8
    • 77953673796 scopus 로고    scopus 로고
    • Emergency department visits involving nonmedical use of selected prescription drugs-United States, 2004-2008
    • Emergency department visits involving nonmedical use of selected prescription drugs-United States, 2004-2008. Morb Mortal Wkly Rep. 2010 ; 59: 705-709
    • (2010) Morb Mortal Wkly Rep , vol.59 , pp. 705-709
  • 9
    • 25844526549 scopus 로고    scopus 로고
    • Trends in abuse of OxyContin® and other opioid analgesics in the United States: 2002-2004
    • Cicero TJ, Inciardi JA, Muñoz A. Trends in abuse of OxyContin® and other opioid analgesics in the United States: 2002-2004. J Pain. 2005 ; 6: 662-672
    • (2005) J Pain , vol.6 , pp. 662-672
    • Cicero, T.J.1    Inciardi, J.A.2    Muñoz, A.3
  • 11
    • 84878694752 scopus 로고    scopus 로고
    • Design of a post-marketing study program to assess the effects of a reformulated extended-release oxycodone tablet on its abuse
    • Coplan PM, Chilcoat HD, Baumgartner T, et al. Design of a post-marketing study program to assess the effects of a reformulated extended-release oxycodone tablet on its abuse. Pharmacoepidemiol Drug Safety. 2012 ; 21: 446
    • (2012) Pharmacoepidemiol Drug Safety , vol.21 , pp. 446
    • Coplan, P.M.1    Chilcoat, H.D.2    Baumgartner, T.3
  • 15
    • 57449112519 scopus 로고    scopus 로고
    • Patterns of abuse among unintentional pharmaceutical overdose fatalities
    • Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. J Am Med Ass. 2008 ; 300: 2613-2620
    • (2008) J Am Med Ass , vol.300 , pp. 2613-2620
    • Hall, A.J.1    Logan, J.E.2    Toblin, R.L.3
  • 16
    • 79953768961 scopus 로고    scopus 로고
    • Development of tamper deterrent formulations: State of the pharmaceutical industry
    • Hamed E, Moe D. Development of tamper deterrent formulations: State of the pharmaceutical industry. Curr Drug Abuse Rev. 2010 ; 3: 139-146
    • (2010) Curr Drug Abuse Rev , vol.3 , pp. 139-146
    • Hamed, E.1    Moe, D.2
  • 18
    • 33846988964 scopus 로고    scopus 로고
    • Mechanisms of prescription drug diversion among drug-involved club- and street-based populations
    • Inciardi JA, Surratt HL, Kurtz SP, et al. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med. 2007 ; 8: 171-183
    • (2007) Pain Med , vol.8 , pp. 171-183
    • Inciardi, J.A.1    Surratt, H.L.2    Kurtz, S.P.3
  • 19
    • 73349124678 scopus 로고    scopus 로고
    • Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: Expert panel report
    • Johanson C-E, Balster RL, Henningfield JE, et al. Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: Expert panel report. Drug Alcohol Depend. 2009 ; 105: S65-71
    • (2009) Drug Alcohol Depend , vol.105 , pp. 65-71
    • Johanson, C.-E.1    Balster, R.L.2    Henningfield, J.E.3
  • 20
    • 79960373515 scopus 로고    scopus 로고
    • Tampering with prescription opioids: Nature and extent of the problem, health consequences, and solutions
    • Katz N, Dart RC, Bailey E, et al. Tampering with prescription opioids: Nature and extent of the problem, health consequences, and solutions. Am J Drug Alcohol Abuse. 2011 ; 37: 205-217
    • (2011) Am J Drug Alcohol Abuse , vol.37 , pp. 205-217
    • Katz, N.1    Dart, R.C.2    Bailey, E.3
  • 21
    • 49649085625 scopus 로고    scopus 로고
    • Internet-based survey of nonmedical prescription opioid use in the United States
    • Katz N, Fernandez K, Chang A, et al. Internet-based survey of nonmedical prescription opioid use in the United States. Clin J Pain. 2008 ; 24: 528-535
    • (2008) Clin J Pain , vol.24 , pp. 528-535
    • Katz, N.1    Fernandez, K.2    Chang, A.3
  • 22
    • 34648813683 scopus 로고    scopus 로고
    • Challenges in the development of prescription opioid abuse-deterrent formulations
    • Katz NP, Adams EH, Chilcoat H, et al. Challenges in the development of prescription opioid abuse-deterrent formulations. Clin J Pain. 2007 ; 23: 648-660
    • (2007) Clin J Pain , vol.23 , pp. 648-660
    • Katz, N.P.1    Adams, E.H.2    Chilcoat, H.3
  • 23
    • 33646068382 scopus 로고    scopus 로고
    • Research design strategies to evaluate the impact of formulations on abuse liability
    • McColl S, Sellers EM. Research design strategies to evaluate the impact of formulations on abuse liability. Drug Alcohol Depend. 2006 ; 83: S52-62
    • (2006) Drug Alcohol Depend , vol.83 , pp. 52-62
    • McColl, S.1    Sellers, E.M.2
  • 24
    • 78549264128 scopus 로고    scopus 로고
    • A flood of opioids, a rising tide of deaths
    • Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010 ; 363: 1981-1985
    • (2010) N Engl J Med , vol.363 , pp. 1981-1985
    • Okie, S.1
  • 26
    • 77956076519 scopus 로고    scopus 로고
    • Opioid formulations designed to resist/deter abuse
    • Raffa RB, Pergolizzi JV. Opioid formulations designed to resist/deter abuse. Drugs. 2010 ; 70: 1657-1675
    • (2010) Drugs , vol.70 , pp. 1657-1675
    • Raffa, R.B.1    Pergolizzi, J.V.2
  • 27
    • 77956707359 scopus 로고    scopus 로고
    • Abuse-deterrent and tamper-resistant opioid formulations: What is their role in addressing prescription opioid abuse?
    • Schneider JP, Matthews M, Jamison RN. Abuse-deterrent and tamper-resistant opioid formulations: What is their role in addressing prescription opioid abuse?. CNS Drugs. 2010 ; 24: 805-810
    • (2010) CNS Drugs , vol.24 , pp. 805-810
    • Schneider, J.P.1    Matthews, M.2    Jamison, R.N.3
  • 28
    • 33947222652 scopus 로고    scopus 로고
    • Relative abuse potential of opioid formulations in Canada: A structured field study
    • Sellers EM, Schuller R, Romach MK, et al. Relative abuse potential of opioid formulations in Canada: A structured field study. J Opioid Manag. 2006 ; 2: 219-227
    • (2006) J Opioid Manag , vol.2 , pp. 219-227
    • Sellers, E.M.1    Schuller, R.2    Romach, M.K.3
  • 29
    • 79953893278 scopus 로고    scopus 로고
    • Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing
    • Smith HS. Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing. Expert Opin Pharmacother. 2011 ; 12: 1111-1125
    • (2011) Expert Opin Pharmacother , vol.12 , pp. 1111-1125
    • Smith, H.S.1
  • 30
    • 0032381728 scopus 로고    scopus 로고
    • Route of drug use and its implications for drug effect, risk of dependence and health consequences
    • Strang J, Bearn J, Farrell M, et al. Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug Alcohol Rev. 1998 ; 17: 197-211
    • (1998) Drug Alcohol Rev , vol.17 , pp. 197-211
    • Strang, J.1    Bearn, J.2    Farrell, M.3
  • 31
    • 84883394067 scopus 로고    scopus 로고
    • Substance Abuse and Mental Health Services Administration (accessed 6 June 2012)
    • Substance Abuse and Mental Health Services Administration (2005) Nonmedical oxycodone users: A comparison with heroin users. Available at: www.samhsa.gov/data/2k5/oxycodoneH/oxycodoneH.htm. (accessed 6 June 2012).
    • (2005) Nonmedical Oxycodone Users: A Comparison with Heroin Users
  • 32
    • 79955787248 scopus 로고    scopus 로고
    • Substance Abuse and Mental Health Services Administration (accessed 6 June 2012)
    • Substance Abuse and Mental Health Services Administration (2007) Patterns and trends in nonmedical prescription pain reliever use: 2002 to 2005. Available at: www.oas.samhsa.gov/2k7/pain/pain.pdf. (accessed 6 June 2012).
    • (2007) Patterns and Trends in Nonmedical Prescription Pain Reliever Use: 2002 to 2005
  • 33
    • 78649648381 scopus 로고    scopus 로고
    • United States Health and Human Services Food and Drug Administration (accessed 3 June 2013)
    • United States Health and Human Services Food and Drug Administration (2010) Guidance for industry: Assessment of abuse potential of drugs. Available at: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM198650.pdf (accessed 3 June 2013).
    • (2010) Guidance for Industry: Assessment of Abuse Potential of Drugs
  • 34
    • 84867881321 scopus 로고    scopus 로고
    • Assessment of a formulation designed to be crush-resistant in prescription opioid abusers
    • Vosburg SK, Jones JD, Manubay JM, et al. Assessment of a formulation designed to be crush-resistant in prescription opioid abusers. Drug Alcohol Depend. 2012 ; 126 (1-2). 206-15
    • (2012) Drug Alcohol Depend , vol.126 , Issue.12 , pp. 206-215
    • Vosburg, S.K.1    Jones, J.D.2    Manubay, J.M.3
  • 35
    • 73449108112 scopus 로고    scopus 로고
    • Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006
    • Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. NCHS Data Brief. 2009 ;: 1-8
    • (2009) NCHS Data Brief , pp. 1-8
    • Warner, M.1    Chen, L.H.2    Makuc, D.M.3
  • 36
    • 84878726433 scopus 로고    scopus 로고
    • Oxycodone extended-release using gel-cap technology to resist alteration and abuse for the treatment of moderate-to-severe pain
    • Webster LR. Oxycodone extended-release using gel-cap technology to resist alteration and abuse for the treatment of moderate-to-severe pain. Pain Manage. 2011 ; 1: 417-425
    • (2011) Pain Manage , vol.1 , pp. 417-425
    • Webster, L.R.1
  • 37
    • 67449100590 scopus 로고    scopus 로고
    • Opioid formulations in development designed to curtail abuse: Who is the target?
    • Webster LR, Bath B, Medve RA. Opioid formulations in development designed to curtail abuse: Who is the target?. Expert Opin Investig Drugs. 2009 ; 18: 255-263
    • (2009) Expert Opin Investig Drugs , vol.18 , pp. 255-263
    • Webster, L.R.1    Bath, B.2    Medve, R.A.3
  • 38
    • 79960879545 scopus 로고    scopus 로고
    • Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users
    • Webster LR, Johnson FK, Stauffer J, et al. Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users. Drugs R D. 2011 ; 11: 259-275
    • (2011) Drugs R D , vol.11 , pp. 259-275
    • Webster, L.R.1    Johnson, F.K.2    Stauffer, J.3
  • 39
    • 77957922787 scopus 로고    scopus 로고
    • Route of administration for illicit prescription opioids: A comparison of rural and urban drug users
    • Young AM, Havens JR, Leukefeld CG. Route of administration for illicit prescription opioids: A comparison of rural and urban drug users. Harm Reduct J. 2010 ; 7: 24
    • (2010) Harm Reduct J , vol.7 , pp. 24
    • Young, A.M.1    Havens, J.R.2    Leukefeld, C.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.